Life-Threatening Consequences
A charity has issued a stark warning about a severe shortage of a crucial drug that aids in food digestion, potentially putting lives at risk. Neil Pearce from PLANETS charity expressed deep concerns to the government regarding the lack of pancreatic enzyme replacement therapy (PERT).
Patient Struggles
Patients who rely on PERT to digest food can face severe consequences such as diarrhea, weight loss, and malnutrition without it. Some have resorted to drastic measures like cutting down on meals to make their remaining drugs last.
Impact on Patients
The drug, crucial for those lacking digestive enzymes, is essential for conditions like pancreatic cancer, cystic fibrosis, and chronic pancreatitis. An estimated 20,000 individuals in the UK have been affected by the shortage of PERT.
Urgent Calls for Action
Neil warned of potential excess and avoidable deaths if interim solutions are not promptly put in place. Patients have been struggling to access the medication, with some traveling long distances to find pharmacies with supplies in stock.
Global Supply Issues
The shortage of PERT adds to the ongoing challenges with medicine supply in the UK, including issues with hormone replacement therapy drugs, ADHD medicines, antidepressants, and insulin. The situation has raised concerns about the impact on patients' health.
Seeking Solutions
Pancreatic Cancer UK offers support for those affected by the shortage of PERT, providing access to specialist nurses who can assist with managing the situation. The Department of Health and Social Care is working to address the supply chain issues and ensure alternative products are available.
